Todd Gluth

Cooley advised Radionetics Oncology, a biotechnology company discovering and developing novel small molecule G protein-coupled receptor (GPCR)-targeted radiopharmaceuticals to treat a broad range of solid tumors, on the formation of a strategic agreement with Eli Lilly to take forward Radionetics’ proprietary GPCR-targeting small molecule radiopharmaceuticals. Under the terms of the agreement, Radionetics received a $140 million up-front cash payment. Additionally, Lilly obtained the exclusive right to acquire Radionetics for $1 billion upon conclusion of an exercise period.

Cooley advised Dutch Bros (NYSE: BROS), a publicly held drive-thru coffee chain, on its $344 million secondary public offering of Class A common stock.

Cooley advised Life360, a family connection and safety company, on its $178.5 million initial public offering.

Cooley advised AuditBoard, a leading connected risk platform transforming audit, risk, compliance, and environmental, social and governance (ESG) management, on its agreement to be acquired for more than $3 billion by Hg, an experienced and leading global investor in compliance, risk and accounting software over the last 20 years.

Cooley advised PlayAGS, a global gaming supplier of high-performing slots, tables and interactive products, on its definitive agreement to be acquired by the affiliates of Brightstar Capital Partners for $1.1 billion.